When was Myriad Genetics founded?

Myriad Genetics was founded in 1991 and raised its 1st funding round 9 years after it was founded.

Where is Myriad Genetics located?

Myriad Genetics is headquartered in United States. It is registered at Salt Lake City, Utah.

How many employees does Myriad Genetics have?

As of Mar 31, 2026, the latest employee count at Myriad Genetics is 2851.

Is Myriad Genetics a funded company?

Myriad Genetics is a funded company, having raised an undisclosed amount across 8 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jun 29, 2000.

When was the latest funding round of Myriad Genetics?

Myriad Genetics' latest funding was a $***** Post IPO round on Feb 12, 2019, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.17B in funding in 2026 to date.

Where does Myriad Genetics rank among its competitors?

Myriad Genetics ranks 4th amongst 510 active competitors, of which 144 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Guardant Health, which secured $350M in Nov, 2025.

Who are the top competitors of Myriad Genetics?

Myriad Genetics' top competitors include Guardant Health, Invitae and Natera. Among them, Guardant Health secured the most recent funding round in November, 2025.

Myriad Genetics - 2026 Company Profile, Funding & Competitors

Company Details

Developer of molecular diagnostics and personalized medicine for cancer. The company discovers and commercializes molecular diagnostic tests that determine the risk of developing the disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties. The products include Endopredict for the detection of breast cancer and Prolasis for prostate cancer. It also provides diagnostic tests for hereditary cancers and Rheumatoid arthritis.

Website: myriad.com
Social
Registered Address: Salt Lake City, Utah

Key Metrics

Founded Year

1991

Location

United States

Stage

Public

Latest Funding Round

Post IPO, Feb 12, 2019, $*****

Investors

TriplePoint Capital & 7 more

Ranked

4^th among 510 active competitors

Employee Count

2,851 as on Mar 31, 2026

Investment & Acquisitions

Gateway Genomics & 6 more

Similar Companies

Guardant Health & 651 more

Exit Details

Public

View Myriad Genetics' full profile

Myriad Genetics is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Myriad Genetics Inc CIN: 899923 , United States, Deadpooled	Nov 05, 1992	$500M - $1B (As on Dec 31, 2025)	2700 (As on Dec 31, 2023)	-
Myriad CIN: 40203134360 , Latvia, Active	Mar 28, 2018	€0 - €1M (As on Dec 31, 2024)	3 (As on Dec 31, 2023)	-
Myriad Genetics, Inc. CIN: 870494517 , United States, Active	Dec 26, 999	-	2729 (As on Dec 31, 2024)	-

Myriad Genetics got listed on Oct 05, 1995.

Click here to take a look at Myriad Genetics's IPO in detail

Myriad Genetics has raised funding over 8 rounds. Its first funding round was on Jun 29, 2000. Myriad Genetics has 8 institutional investors.

Here is the list of recent funding rounds of Myriad Genetics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 12, 2019	4129782	Post IPO	4014671	4951731	7386108	7502045
Jan 24, 2011	9850550	Grant (prize money)	6678115	5697144	1122022	HHS
Mar 03, 2010	2193511	Grant (prize money)	4909348	5062407	7820849	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Myriad Genetics's funding rounds and investors

Myriad Genetics' employee count trend

Myriad Genetics has 2,851 employees as of Mar 26. Here is Myriad Genetics's employee count trend over the years:

Employee count trend for Myriad Genetics

Uncover Myriad Genetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Myriad Genetics include Guardant Health, Invitae and Natera. Here is the list of Top 10 competitors of Myriad Genetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	Khosla Ventures, Orbimed & 25 others	79/100
2nd	Invitae 2010, San Francisco (United States), Public	Provider of home-based genetic test for individuals	$190M	Deerfield, Perceptive Advisors & 22 others	77/100
3rd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Foresite Capital & 17 others	77/100
4th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	TriplePoint Capital, New Venturetec & 6 others	72/100
5th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Casdin Capital & 11 others	71/100
6th	Fulgent Genetics 2011, Temple City (United States), Acquired	Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer	$34.8M	-	71/100
7th	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	71/100
8th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Braidwell & 19 others	70/100
9th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
10th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Myriad Genetics's competitors? Click here to see the top ones

Myriad Genetics has made 2 investments in companies including DLF India and RainDance. Myriad Genetics has also acquired 5 companies including Gateway Genomics and Assurex Health.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Nov 03, 2022	Acquisition	Gateway Genomics	2015	San Diego (United States)
Mar 29, 2019	Investments	DLF India	1947	Gurugram (India)
Aug 03, 2016	Acquisition	Assurex Health	2006	Mason (United States)